These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. Refaat M; McNamara D; Teuteberg J; Kormos R; McCurry K; Shullo M; Toyoda Y; Bermudez C J Heart Lung Transplant; 2008 Jun; 27(6):699-700. PubMed ID: 18503977 [No Abstract] [Full Text] [Related]
6. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection. Vora SB; Brothers AW; Englund JA J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263 [TBL] [Abstract][Full Text] [Related]
7. Successful outcome of a disseminated adenovirus infection 6 years after allogeneic bone marrow transplantation. Willems L; Lagrange-Xélot M; Gallien S; Robin M; Scieux C; Socié G; Molina JM Bone Marrow Transplant; 2008 Feb; 41(4):411-2. PubMed ID: 18026146 [No Abstract] [Full Text] [Related]
9. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Muller WJ; Levin MJ; Shin YK; Robinson C; Quinones R; Malcolm J; Hild E; Gao D; Giller R Clin Infect Dis; 2005 Dec; 41(12):1812-6. PubMed ID: 16288409 [TBL] [Abstract][Full Text] [Related]
10. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Fanourgiakis P; Georgala A; Vekemans M; Triffet A; De Bruyn JM; Duchateau V; Martiat P; De Clercq E; Snoeck R; Wollants E; Rector A; Van Ranst M; Aoun M Clin Infect Dis; 2005 Jan; 40(1):199-201. PubMed ID: 15614713 [TBL] [Abstract][Full Text] [Related]
12. Should intralesional cidofovir be used for recurrent respiratory papillomatosis? Donne A; Rothera M; Homer J Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168 [No Abstract] [Full Text] [Related]
13. Topical cidofovir for viral warts in children. Fernández-Morano T; del Boz J; González-Carrascosa M; Tortajada B; de Troya M J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1487-9. PubMed ID: 21261749 [No Abstract] [Full Text] [Related]
14. 1% topical cidofovir used as last alternative to treat viral infections. Briand S; Milpied B; Navas D; Thomare P; Stalder JF J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429 [No Abstract] [Full Text] [Related]
16. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Ribaud P; Scieux C; Freymuth F; Morinet F; Gluckman E Clin Infect Dis; 1999 Mar; 28(3):690-1. PubMed ID: 10194105 [No Abstract] [Full Text] [Related]
17. Successful response to cidofovir of adenovirus hepatitis during chemotherapy in a child with hepatoblastoma. Mateos ME; López-Laso E; Pérez-Navero JL; Peña MJ; Velasco MJ J Pediatr Hematol Oncol; 2012 Oct; 34(7):e298-300. PubMed ID: 22935664 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus infections in heart transplantation. Florescu DF; Kwon JY; Dumitru I Cardiol Rev; 2013; 21(4):203-6. PubMed ID: 23535527 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men. Wan J; Vittorio CC; Abuabara K; Kurd SK; Musiek A; Steinemann JM; Gelfand JM Arch Dermatol; 2012 Feb; 148(2):257-9. PubMed ID: 22351834 [No Abstract] [Full Text] [Related]
20. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model. Romanowski EG; Gordon YJ Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]